SCHEMBL7974418

SCHEMBL7974418

Nc1cccc(-c2nc(=O)c3c(ncn3Cc3ccc(F)cc3)[nH]2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 2/20 0.39
PARN O95453 1/20 0.39
ACP1 P24666 2/20 0.37
PNP P00491 1/20 0.37
EGFR P00533 1/20 0.37
LMNA P02545 1/20 0.37
TYMS P04818 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
TP53 P04637 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
PRMT1 Q99873 1/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988736 0.92 ACP1 (0.45) CNOT7PARNACP1LMNAKDM4E
SCHEMBL7985302 0.91 ROCK2 (0.41) CNOT7PARNACP1PNPEGFR
SCHEMBL7984663 0.90 CNOT7 (0.49) CNOT7PARNPNPKDM4EALDH1A1
SCHEMBL7988784 0.90 MAPK1 (0.43) CNOT7PARNACP1LMNASMN1; SMN2
SCHEMBL7984427 0.90 HPGD (0.44) CNOT7PARNACP1PNPLMNA
Hydrochloric Acid SCHEMBL7987663 0.89 CNOT7 (0.48) CNOT7PARNPNPKDM4EALDH1A1
SCHEMBL7985619 0.89 CNOT7 (0.41) CNOT7PARNACP1EGFRLMNA
SCHEMBL7986522 0.88 CNOT7 (0.48) CNOT7PARNACP1PNPLMNA
SCHEMBL7991403 0.87 ABCC8 (0.43) CNOT7PARNPNPKDM4EALDH1A1
SCHEMBL7984283 0.87 CNOT7 (0.43) CNOT7PARNACP1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed